Cargando…
Everolimus safety and efficacy for renal angiomyolipomas associated with tuberous sclerosis complex: a Spanish expanded access trial
BACKGROUND: Renal angiomyolipomas (AML) are usual manifestations of tuberous sclerosis complex (TSC) that may cause aneurism-related haemorrhages and renal impairment. Everolimus has emerged as an alternative to surgery/embolization. We provide further insight into everolimus safety and efficacy for...
Autores principales: | Robles, Nicolás Roberto, Peces, Ramón, Gómez-Ferrer, Álvaro, Villacampa, Felipe, Álvarez-Ossorio, Jose Luis, Pérez-Segura, Pedro, Morote, Juan, Herrera-Imbroda, Bernardo, Nieto, Javier, Carballido, Joaquín, Anido, Urbano, Valero, Marian, Meseguer, Cristina, Torra, Roser |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037621/ https://www.ncbi.nlm.nih.gov/pubmed/27669821 http://dx.doi.org/10.1186/s13023-016-0517-9 |
Ejemplares similares
-
Recommendations for imaging-based diagnosis and management of renal angiomyolipoma associated with tuberous sclerosis complex
por: Buj Pradilla, María José, et al.
Publicado: (2017) -
Assessing the effectiveness of rapamycin on angiomyolipoma in tuberous sclerosis: a two years trial
por: Cabrera-López, Cristina, et al.
Publicado: (2012) -
Sequential everolimus for angiomyolipoma associated with tuberous sclerosis complex: a prospective cohort study
por: Gu, Liangyou, et al.
Publicado: (2021) -
Low-Dose Everolimus Maintenance Therapy for Renal Angiomyolipoma Associated With Tuberous Sclerosis Complex
por: Luo, Cong, et al.
Publicado: (2021) -
Individualized everolimus treatment for tuberous sclerosis-related angiomyolipoma promotes treatment adherence and response
por: Chung, Noelle K X, et al.
Publicado: (2022)